NewsBenzingaInsmed : BPA du T3 à (0,46 $) inférieur à l’estimation de (0,43 $), ventes à 524,428 M$ supérieures à l’estimation de 501,350 M$ Insmed : BPA du T3 à (0,46 $) inférieur à l’estimation de (0,43 $), ventes à 524,428 M$ supérieures à l’estimation de 501,350 M$ Benzinga 2026.10.29 11:11 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Commercial Metals, Lowers Price Target to $63 Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37 If You Invested $100 In Cenovus Energy Stock 5 Years Ago, You Would Have This Much Today Wells Fargo Maintains Overweight on Cleveland-Cliffs, Raises Price Target to $18 TD Cowen Maintains Buy on BWX Technologies, Lowers Price Target to $180